statistiche ricercatore

Continente	#
AS - Asia	590
EU - Europa	523
NA - Nord America	319
SA - Sud America	65
Continente sconosciuto - Info sul continente non disponibili	12
AF - Africa	11
Totale	1.520

Nazione	#
US - Stati Uniti d'America	300
SG - Singapore	198
RU - Federazione Russa	154
IN - India	119
GB - Regno Unito	114
UA - Ucraina	106
VN - Vietnam	105
CN - Cina	93
DE - Germania	62
BR - Brasile	54
IT - Italia	35
HK - Hong Kong	31
FR - Francia	12
NL - Olanda	11
AT - Austria	10
CA - Canada	10
JP - Giappone	8
KR - Corea	8
PH - Filippine	6
CI - Costa d'Avorio	5
FI - Finlandia	5
AR - Argentina	4
BD - Bangladesh	4
AZ - Azerbaigian	3
BG - Bulgaria	3
EC - Ecuador	3
MX - Messico	3
PL - Polonia	3
SE - Svezia	3
TH - Thailandia	3
AE - Emirati Arabi Uniti	2
CL - Cile	2
DO - Repubblica Dominicana	2
ID - Indonesia	2
KE - Kenya	2
TT - Trinidad e Tobago	2
TW - Taiwan	2
CO - Colombia	1
DZ - Algeria	1
GR - Grecia	1
HN - Honduras	1
IE - Irlanda	1
IL - Israele	1
IQ - Iraq	1
IR - Iran	1
JM - Giamaica	1
KZ - Kazakistan	1
LB - Libano	1
LT - Lituania	1
LY - Libia	1
MD - Moldavia	1
NG - Nigeria	1
SK - Slovacchia (Repubblica Slovacca)	1
TN - Tunisia	1
UZ - Uzbekistan	1
VE - Venezuela	1
Totale	1.508

Nome	#
Direct Current Cardioversion in Atrial Fibrillation Patients on Edoxaban Therapy Versus Vitamin K Antagonists: a Real-world Propensity Score–Matched Study	378
Edoxaban (LIXIANA®) in the treatment of venous thromboembolism	225
Intermuscular technique for implantation of the subcutaneous implantable defibrillator: a propensity-matched case-control study	156
Cardiac pacing procedures during coronavirus disease 2019 lockdown in Southern Italy: insights from Campania Region	132
Non-vitamin K vs vitamin K oral anticoagulants in patients aged > 80 year with atrial fibrillation and low body weight	119
Early evaluation of atrial high rate episodes using remote monitoring in pacemaker patients: Results from the RAPID study	104
Clinical Benefit of Direct Oral Anticoagulants Versus Vitamin K Antagonists in Patients with Atrial Fibrillation and Bioprosthetic Heart Valves	104
Remote monitoring of implantable loop recorders reduces time to diagnosis in patients with unexplained syncope: a multicenter propensity score-matched study	104
Cardiac implantable electronic devices replacements in patients followed by remote monitoring during COVID-19 lockdown	100
Non vitamin k antagonist oral anticoagulants in atrial fibrillation patients scheduled for electrical cardioversion: A real-life propensity score matched study	98
Totale	1.520

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	389	0	0	0	0	0	0	0	4	101	220	57	7
2022/2023	34	5	0	1	0	5	3	0	1	5	10	3	1
2023/2024	58	0	4	2	5	0	15	4	9	1	3	13	2
2024/2025	334	10	19	2	3	16	8	35	27	23	47	115	29
2025/2026	684	72	56	95	67	99	42	59	43	83	38	15	15
2026/2027	17	14	3	0	0	0	0	0	0	0	0	0	0
Totale													1.520